Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael E Pollock

Showing results (171-180 of 234) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcomaPeter W T Pisters, Matthew T Ballo, Mark J Fenstermacher, et al.
Cancer|December 22, 2006
Periosteal margin in soft-tissue sarcomaPatrick P Lin, Eduardo Diaz Pino, Anne N Normand, et al.
Annals of Surgery|September 26, 2007
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomasPeter W T Pisters, Raphael E Pollock, Valerae O Lewis, et al.
Annals of Surgical Oncology|February 24, 2006
Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcomaTimothy M Pawlik, Peter W T Pisters, Lynn Mikula, et al.
Annals of Surgical Oncology|March 19, 2014
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumorsBrian K Bednarski, Dejka M Araujo, Min Yi, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Annals of Surgery|May 1, 2002
Preoperative predictors of survival after resection of small hepatocellular carcinomasJeffrey D Wayne, Gregory Y Lauwers, Iwao Ikai, et al.
Plos One|October 14, 2022
Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumorsDanielle Almeida Braggio, Fernanda Costas C de Faria, David Koller, et al.
American Journal of Surgery|December 16, 2003
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?Courtney L Scaife, Kelly K Hunt, Shreyaskumar R Patel, et al.
Pageof 24

Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcomaPeter W T Pisters, Matthew T Ballo, Mark J Fenstermacher, et al.
Cancer|December 22, 2006
Periosteal margin in soft-tissue sarcomaPatrick P Lin, Eduardo Diaz Pino, Anne N Normand, et al.
Annals of Surgery|September 26, 2007
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomasPeter W T Pisters, Raphael E Pollock, Valerae O Lewis, et al.
Annals of Surgical Oncology|February 24, 2006
Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcomaTimothy M Pawlik, Peter W T Pisters, Lynn Mikula, et al.
Annals of Surgical Oncology|March 19, 2014
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumorsBrian K Bednarski, Dejka M Araujo, Min Yi, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Annals of Surgery|May 1, 2002
Preoperative predictors of survival after resection of small hepatocellular carcinomasJeffrey D Wayne, Gregory Y Lauwers, Iwao Ikai, et al.
Plos One|October 14, 2022
Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumorsDanielle Almeida Braggio, Fernanda Costas C de Faria, David Koller, et al.
American Journal of Surgery|December 16, 2003
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?Courtney L Scaife, Kelly K Hunt, Shreyaskumar R Patel, et al.
Pageof 24